TVM Life Science Ventures backs Esperas Pharma

TVM Life Science Ventures and Fonds de solidarité FTQ have made an investment in Esperas Pharma, a Montreal-based biopharmaceutical company focused on triple negative breast cancer. No financial terms were disclosed.

Thrasos Innovation raises $21 mln

Thrasos Innovation has raised a $21 million financing round from investors including the Fonds de solidarité FTQ, BDC Venture Capital and SR One. Thrasos, of Montreal, is biotech focused on developing therapies to treat kidney disease.

Coveo Secures Funding Led by Tandem

Search technology provider Coveo has secured $18 million in funding led by Canadian late-stage technology investment firm Tandem Expansion Fund. All major existing investors also participated in the round, including BDC Venture Capital, Propulsion Ventures SEC and Fonds de solidarité FTQ.

Milestone Pharma Inks $13M

Milestone Pharmaceuticals Inc., a Montreal-based cardiovascular drug development company, has raised $13 million in fresh capital. Pappas Ventures, the Business Development Bank of Canada and GO Capital co-led the round. Fonds de solidarité FTQ, iNovia Healthcare Ventures and Fonds Bio-Innovation also participated. The money will be used for continued development. As a result of the round, Eric Linsley, managing partner of Pappas Ventures; Scott Weiner, senior principal at Pappas Ventures; and Dominic Jaikaran, principal at BDC Health Venture Fund, will join Milestone’s board.

PE HUB Community

Join the 12518 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget